268 related articles for article (PubMed ID: 22538155)
1. Clinical use of U-500 regular insulin: review and meta-analysis.
Reutrakul S; Wroblewski K; Brown RL
J Diabetes Sci Technol; 2012 Mar; 6(2):412-20. PubMed ID: 22538155
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc Analysis.
Hood RC; Chen Y; Sindelar DK; Ly T; Juneja R; Pollom RD; Ilag L; Wysham C
Endocr Pract; 2021 Aug; 27(8):783-789. PubMed ID: 33515757
[TBL] [Abstract][Full Text] [Related]
3. Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.
Grunberger G; Bhargava A; Ly T; Zisser H; Ilag LL; Malone J; Fan L; Zhang S; Johnson J
Diabetes Obes Metab; 2020 Mar; 22(3):434-441. PubMed ID: 31865633
[TBL] [Abstract][Full Text] [Related]
4. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
7. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
9. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
10. IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
Vigersky RA; Huang S; Cordero TL; Shin J; Lee SW; Chhabra H; Kaufman FR; Cohen O;
Endocr Pract; 2018 May; 24(5):446-452. PubMed ID: 29847166
[TBL] [Abstract][Full Text] [Related]
11. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
12. When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin Pump.
Cohen O; Filetti S; Castañeda J; Maranghi M; Glandt M
Diabetes Care; 2016 Aug; 39 Suppl 2():S180-6. PubMed ID: 27440831
[TBL] [Abstract][Full Text] [Related]
13. Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key.
Cochran EK; Valentine V; Samaan KH; Corey IB; Jackson JA
Diabetes Educ; 2014; 40(2):153-65. PubMed ID: 24159006
[TBL] [Abstract][Full Text] [Related]
14. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
Blevins T; Lane W; Rodbard D; Sindelar D; Fan L; Ellinor K; Ilag L; Ly T; Johnson J
Diabetes Technol Ther; 2021 Jan; 23(1):51-58. PubMed ID: 32631081
[No Abstract] [Full Text] [Related]
15. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
16. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.
St Charles ME; Sadri H; Minshall ME; Tunis SL
Clin Ther; 2009 Mar; 31(3):657-67. PubMed ID: 19393856
[TBL] [Abstract][Full Text] [Related]
17. Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction.
Chlup R; Runzis S; Castaneda J; Lee SW; Nguyen X; Cohen O
Diabetes Technol Ther; 2018 Feb; 20(2):153-159. PubMed ID: 29215299
[TBL] [Abstract][Full Text] [Related]
18. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
Giménez M; Elías I; Álvarez M; Quirós C; Conget I
Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcomes in a study of human regular U-500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes.
Chen J; Fan L; Peng X; Ilag L; Ly T; Johnson J
Diabetes Obes Metab; 2021 Jan; 23(1):240-244. PubMed ID: 32893428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]